EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study

Masahiro Ohira, Gaku Aoki, Yasushi Orihashi, Kenichi Yoshimura, Takeo Toshima, Etsuro Hatano, Susumu Eguchi, Taizo Hibi iD, Kiyoshi Hasegawa, Yuzo Umeda, Takuya Hashimoto, Yasushi Hasegawa iD und 18 weitere

BJS Open · 2024

DOI: 10.1093/bjsopen/zrae079 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJS Open, 2024. Verfasst von Masahiro Ohira und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Living Donors. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Validating the expanded criteria for living donor liver transplantation for hepatocellular carcinoma using national data is highly significant. The aim of this study was to evaluate the validity of the new Japanese criteria for living donor liver transplantation for hepatocellular carcinoma patients and identify factors associated with a poor prognosis using the Japanese national data set.

Methods

The study population comprised patients who underwent living donor liver transplantation for hepatocellular carcinoma at 37 centres in Japan between 2010 and 2018. In a nationwide survey, the overall survival and recurrence-free survival rates were evaluated based on the new Japanese criteria for applying the 5-5-500 rule when extending the indication beyond the Milan criteria. Prognostic factors within the Japanese criteria were determined using the Cox proportional hazards model.

Results

Patients within (485 patients) and beyond (31 patients) the Japanese criteria exhibited 5-year overall survival rates of 81% and 58% and 5-year recurrence-free survival rates of 77% and 48% respectively. Patients who met the Milan criteria, but not the 5-5-500 rule, had poorer outcomes. Multivariate analysis for 474 patients identified a neutrophil-to-lymphocyte ratio greater than or equal to 5 and a history of hepatectomy as independent risk factors.

Conclusion

This nationwide survey confirms the validity of the Japanese criteria. The poor prognostic factors within the Japanese criteria include a neutrophil-to-lymphocyte ratio greater than or equal to 5 and previous hepatectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationLiving DonorsHumansMaleJapanFemaleMiddle AgedAdultRisk FactorsAgedPrognosisCohort StudiesSurvival RateHepatectomyProportional Hazards ModelsDisease-Free SurvivalEast Asian People

Autor:innen und Institutionen

  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Medical Centre for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Biostatistics, Clinical Research Centre in Hiroshima, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

ORCID-Profile: Taizo Hibi, Yasushi Hasegawa, Hidetoshi Eguchi, Hideki Ohdan

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Ohira, M., Aoki, G., Orihashi, Y., Yoshimura, K., Toshima, T., Hatano, E., Eguchi, S., Hibi, T., Hasegawa, K., Umeda, Y., Hashimoto, T., Hasegawa, Y., Nobori, S., Ogura, Y., Nitta, H., Egawa, H., Eguchi, H., Takada, Y., Ueda, Y., …, & Japanese Liver Transplantation Society (2024). Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study. BJS Open. https://doi.org/10.1093/bjsopen/zrae079

Vancouver

Ohira M, Aoki G, Orihashi Y, Yoshimura K, Toshima T, Hatano E, et al. Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study. BJS Open. 2024. doi:10.1093/bjsopen/zrae079

BibTeX
@article{Ohira2024,
  author = {Ohira, Masahiro and Aoki, Gaku and Orihashi, Yasushi and Yoshimura, Kenichi and Toshima, Takeo and Hatano, Etsuro and Eguchi, Susumu and Hibi, Taizo and Hasegawa, Kiyoshi and Umeda, Yuzo and Hashimoto, Takuya and Hasegawa, Yasushi and Nobori, Shuji and Ogura, Yasuhiro and Nitta, Hiroyuki and Egawa, Hiroto and Eguchi, Hidetoshi and Takada, Yasutsugu and Ueda, Yoshihide and Kasahara, Mureo and Kawachi, Shigeyuki and Soejima, Yuji and Tokushige, Katsutoshi and Nagano, Hiroaki and Haga, Hironori and Fukumoto, Takumi and Mochida, Satoshi and Umeshita, Koji and Ohdan, Hideki and Japanese Liver Transplantation Society, Japanese Liver Transplantation Society},
  title = {Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study},
  journal = {BJS Open},
  year = {2024},
  doi = {10.1093/bjsopen/zrae079}
}
Kostenlos starten →